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ORIGINAL RESEARCH
Implementing a Clinical Practice Guideline for Pediatric 
Appendicitis Safely Reduced Health Care Use and Improved 
Antimicrobial Stewardship
Jack P. Vernamonti, MD1, Robin Cotter, MD, MA2, Jennifer Jubulis, MD3, Kartikey Pandya, MD4 
1Department of Surgery, Maine Medical Center, Portland, Maine, 2Department of Surgery, Dartmouth-Hitchcock Medical 
Center, Lebanon, New Hampshire, 3Department of Infectious Disease, Maine Medical Center, Portland, Maine, 4Department 
of Surgery, Division of Pediatric Surgery, Maine Medical Center, Portland, Maine
Introduction:  Appendicitis is the most common emergency surgical disease in children. Those with perforated 
appendicitis have a more complicated and varied course. Through a clinical practice guideline 
(CPG), we sought to reduce computed tomography scans, laboratory draws, and exposure to broad-
spectrum antibiotics without adversely affecting length of stay, hospital readmission, or repeat antibiotic 
administration.
Methods: Electronic records were retrospectively reviewed before and after CPG implementation, and data was 
collected in REDCap. Results were reported as mean or percent incidence, and statistical analysis was 
done using a Student’s t-test, Mann-Whitney U test, or Pearson’s χ2 with P < .05 considered significant.
Results: One hundred patients with a perforated appendix (50 before and 50 after CPG implementation) were 
included in our analysis. Length of stay (4.98 vs 4.46 days; P = .25), hospital readmission rate (10% vs 
14%; P = .54), and additional antibiotic administration (2% vs 4%; P = .56) did not change. We observed 
no difference in the Pediatric Appendicitis Score (9 vs 9; P = .48) and a trending increase in evaluation 
at an outside hospital (56% vs 74%; P = .06). Rates of computed tomography scans did not differ overall 
(50% vs 40%; P = .31), but showed a decreasing trend at our institution (30% vs 12%; P = .06). We also 
found fewer post-operative laboratory studies (90% vs 38%; P < .01) and patients who received broad-
spectrum intravenous antibiotics (92% vs 18%; P < .01).
Discussion:  Through implementing the CPG we were able to understand our practice patterns and identify 
opportunities for improvement. Patients with perforated appendicitis were selected for study because 
they were affected by all components of the CPG and allowed for total adherence to be our primary 
outcome. Total adherence was set as the primary outcome knowing it would be difficult to achieve, but 
would also better identify opportunity for improvement and provide comprehensive assessment of the 
guideline.  
Conclusions:  Implementing a multidisciplinary CPG reduced health care use and improved antimicrobial stewardship 
without increasing complications in pediatric acute appendicitis.
Keywords:  appendicitis, clinical practice guideline, antimicrobial stewardship, quality improvement
Appendicitis is the most common emergency surgical disease in children. Practice patterns have evolved in response to the 
pediatric appendicitis semi-annual report produced 
by the National Surgical Quality Improvement 
Program of the American College of Surgeons.1 
These quality metrics include components from 
the initial diagnosis, as well as management and 
post-operative complications associated with 
pediatric appendicitis. They are also designed 
to give institutions guidance on opportunities for 
standardization and improvement. At our institution, 
it was noticed that there was variability in how 
perforated appendicitis was managed in patients 
initially seen at our facility and those transferred 
from referring hospitals. Clinical practice guidelines 
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Regimen Antibiotics
Intravenous Ceftriaxone (50 mg/kg/q24hrs, 
max 2 gm/day) or ciprofloxacin 
(10 mg/kg/q12hrs, max 750 mg/
dose)
-Plus-
Metronidazole (10 mg/kg/q8hrs, 
max 1.5 gm/day)
Intra-operative 
(if IV regimens 
not initiated 
before arrival in 
operating room)
Cefotetan (40 mg/kg/dose, max 
2 gm)
Oral (to com-
plete a total 
course of 7-10 
days of antibiot-
ic therapy)
Cefdinir (7 mg/kg/dose q12h, 
up to 300 mg q12h) or cipro-
floxacin (10 mg/kg/q12hrs, max 
750 mg/dose)
-Plus-
Metronidazole (10 mg/kg/q8hrs, 
max 1.5 gm/day)
(CPG) have been documented to change physician 
practice, standardize management, and improve 
outcomes.2  The pediatric emergency medicine, 
radiology, infectious disease, and surgery 
divisions partnered to design and implement a 
multidisciplinary CPG for pediatric appendicitis 




•	 Avoid routine post-operative CRP/WBC
•	 Transition to oral antibiotics based on toler-
ating enteral feeds, remaining afebrile, and 
clinical improvement in activity and pain
•	 Post-operative labs, imaging, and interven-
tions as directed by clinical course 
METHODS
Setting
This study was conducted at Maine Medical Center, 
a 637-bed academic medical center located in 
Portland, Maine. Housed within this larger institution, 
the Barbara Bush Children’s Hospital comprises 140 
beds, including a 51-bed continuing care nursery 
and neonatal intensive care unit (level II/III), a 10-
bed pediatric intensive care unit, and a 10-bed 
pediatric emergency department. The hospital 
serves as a training site for over 240 residents and 
fellows, most of whom rotate through and interact 
with the pediatric population. Surgical patients are 
cared for by 5 pediatric surgeons and 2 advanced 
practice providers. This study was approved by the 
Maine Medical Center Institutional Review Board.
Figure 1. Clinical Practice Guideline. A, Pre-operative algorithm. B, Antibiotic selection. C, Post-operative 
management. bHCG, beta Human Chorionic Gonadotropin; CBC, complete blood cell count; CRP, 
C-reactive protein; CT, computed tomography; IV, intravenous; PAS, Pediatric Appendicitis Score; UA, 
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Development of the CPG
After literature review, we developed a CPG focusing 
on evaluating patients with suspected appendicitis. 
The algorithm relied on the Pediatric Appendicitis 
Score (PAS) and C-reactive protein (CRP)4,5 (added 
for initial triage). Pre-existing familiarity with CRP 
values as an inflammatory marker for appendicitis 
led to its inclusion in our institutional algorithm. 
The PAS is a tool that assigns weighted values to 
common symptoms and laboratory evaluation of 
appendicitis: fever, anorexia, emesis, peritonitis, 
right lower quadrant pain, leukocytosis, and 
neutrophilia. Patients are given a score 0 through 
10, with 10 being most likely to have appendicitis. 
The score is most predictive at either end of the 
spectrum, and our cutoffs and interpretation are 
incorporated into the decision algorithm in Figure 1. 
If the diagnosis remained in question after 
compiling the history, physical exam, and laboratory 
data, our CPG directed providers to first use an 
ultrasound for further workup. In discussion with 
the radiology division, standardized reporting for 
pediatric appendiceal ultrasounds were adopted6 
and followed the American College of Radiology 
guidelines for obtaining ultrasound before 
considering a contrast enhanced, abdominal-
pelvic computed tomography (CT) scan.7 The CPG 
allowed for CT scan use at surgeon discretion in 
the Emergency Department versus admission and 
observation with no CT scan; however, admission 
and observation were encouraged.
The next phase of the CPG sought to reduce 
exposure to broad-spectrum antibiotics defined as 
piperacillin-tazobactam or ampicillin-sulbactam for 
intravenous (IV) therapy and amoxicillin-clavulanate 
for oral therapy. The Barbara Bush Children’s 
Hospital has a pediatric-specific antibiogram, which 
we used to select the initial regimen for the CPG. The 
IV antibiotics began when the decision was made 
to offer appendectomy. If the patient was at low risk 
for appendicitis and being admitted for observation, 
they were discouraged from being given antibiotics 
that could mask their serial abdominal exams. 
Intraoperative culture data from 40 patients with 
perforated appendicitis was collected to validate 
regimens previously published (Table 1). Our 
antibiogram revealed strong susceptibility to both 
ceftriaxone and ciprofloxacin, with decreased 
susceptibility of Escherichia coli to ampicillin-
sulbactam. After considering local resistance 
patterns, and in discussion with our division of 
pediatric infection disease, IV antibiotic regimen 
was narrowed from either ampicillin-sulbactam 
or piperacillin-tazobactam to metronidazole 
and either ceftriaxone or ciprofloxacin (if there 
was a documented penicillin allergy).8,9 We also 
incorporated early transition to oral metronidazole 
and cefdinir or ciprofloxacin in perforated 
appendicitis based on clinical improvement (eg, 
resolved fevers, diminished abdominal pain, 
resolution of ileus). Total antibiotic therapy was 
given for 7 to 10 days based on recommendations 
from the American Pediatric Surgical Association.10 
The specific duration within this window was 
determined by the attending surgeon.
Finally, before the CPG, our practice routinely 
assessed for normalized CRP and leukocytosis 
before discharge on oral antibiotics. A protocol was 
adopted to determine suitability for oral antibiotics, 
discharge based on clinical criteria, and avoid 
routine labs unless clinically indicated.
The CPG was developed through a multidisciplinary 
approach with input from corresponding 
departments. There was then a period of education 
in which the CPG lead met with representatives from 
each department and discussed implementation. 
Patient capture for adherence was done after a 
6-month roll-out period to allow provider education. 
The education and distribution began in January 
2017 with the goal to fully adopt the CPG for the 
academic year starting July 2017. Patients for this 
study were selected before education began for the 
control group and after the roll-out period for the 
intervention group to avoid bias during the transition. 
This study was an analysis of interval adherence, 
and feedback from the CPG lead was done ad hoc 
with respective department contributors.
Study design
Patients with perforated appendicitis present later, 
and have a longer, more severe clinical course 
than those with simple appendicitis. They were 
also at the highest risk for adverse events with 
our new management protocol, and the population 
that would be most affected by all aspects of the 
CPG. Therefore, we selected this group of patients 
to study. Our inclusion criteria were pediatric 
patients under age 18 years who had perforated 
appendicitis and underwent surgical intervention. 
We identified the first 50 patients immediately 
before and after implementation of the CPG in a 
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27 (68) Ampicillin 19 (70) 0 8 (30) 0
Ampicillin/
Sulbactam
20 (74) 3 (11) 4 (15) 0
Cefazolin; trimethoprim/ 
sulfamethoxazole
24 (89) 0 3 (11) 0





27 (100) 0 0 0
Streptococcus 
species 
16 (40) Penicillin; ceftriaxone; 
vancomycin
6 (38) 0 0 10 (62)
Pseudomonas 8 (20) Imipenem; meropenem 6 (75) 0 1 (12) 1 (12)
Piperacillin/ tazobactam; 
cefepime; quinolone;  
gentamicin; amikacin








5 (12.5) NA 0 0 0 5 (100)
Abbreviations: NA, not applicable.
*Summarizes bacterial species cultures from routine intraoperative culture swabs from patients with a 
perforated appendectomy treated between October 2015 and October 2018. Sensitivities to antibiotics are 
grouped from most to least resistant for each organism.
quality improvement study. This selection was done 
to focus on the effect of the CPG and separate its 
effect from general practice trends. Patients were 
excluded if they had perforated appendicitis with 
abscess managed by percutaneous drain, non-
perforated appendicitis, or unspecified abdominal 
pain managed with observation.
The primary endpoint was defined as full adherence 
to the CPG. The secondary endpoints were post-
operative complications defined as additional 
surgical or interventional radiology procedures, 
including peripherally inserted central catheters or 
central venous catheters, length of stay, hospital 
readmission or emergency department presentation, 
and repeat antibiotic administration (after completing 
an initial course). 
Records were identified using appendectomy 
billing codes, and then manually verified through 
operative reports. Patient data was captured 
from October 2015 through October 2018. Due to 
variability in definitions of perforated appendicitis11, 
we defined perforation as an appendix with either 
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a free fecalith or visible hole during surgery.12 All 
data was managed in a REDCap database13,14, and 
records reviewed were analyzed within REDCap 
for data completeness and accuracy. Records with 
ambiguous terminology or data were flagged and 
manually reviewed for consistency and accuracy by 
the entire working group. 
Results were summarized as mean (standard 
deviation) or frequency. Statistical comparisons were 
performed using a Student’s t-test, Mann-Whitney 
U test, or Pearson’s χ2 with P < .05 considered as 
significant (https://www.socscistatistics.com/ and 
Microsoft Excel 2016).
RESULTS
One hundred patients were included in the study. 
Patient characteristics for pre-CPG and post-CPG 
implementation groups are shown in Table 2. There 
was a significant difference in age between pre-
CPG and post-CPG groups (mean age 8.9 ± 3.7 vs 
10.9 ± 3.5 years, P < .01). Between the 2 groups, 
there was no significant difference in sex, race, 
body mass index, evaluation at referring facility, 
or transfer times. There was also no difference in 
initial severity markers, such as PAS, CRP, or white 
blood cell count.




n = 50) P value
Age, mean (SD), y 8.9 (3.7) 10.9 (3.5) <.01
Sex
  Female, No. (%) 22 (44) 15 (30) .15
  Male, No. (%) 28 (56) 35 (70) .15
Caucasian race, No. (%) 43 (86) 48 (96) .08
Black or African American 1 (2) 2 (4) .55
Hispanic/Latinx 2 (4) 0 .15
Asian American Pacific Islander 1 (2) 0 .31
Not reported 3 (6) 0 .08
Seen at outside hospital, No. (%) 28 (56) 37 (74) .06
Transfer times from outside hospital, mean (SD), h 8.2 (12.3) 5.1 (2.0) .17
Antibiotics initiated at outside hospital, No. (%) 18 (64) 24 (65) .96
Pediatric Appendicitis Score 9 9 .48
C-reactive protein, mean (SD), mg/L 123.0 (86.2) 118.4 (84.8) .83
White blood cell count, mean (SD), x102/µL 18.2 (6.1) 18.4 (6.0) .87
Body mass index, mean (SD), kg/m2 19.0 (4.4) 19.9 (4.3) .30
The practice metrics collected for CPG evaluation 
are shown in Table 3 and included post-operative 
laboratory tests, overall rates of CT scans (at the 
referring facility and at our institution), rates of IV 
and oral broad-spectrum antibiotic use, and total 
antibiotic duration. We also assessed adherence to 
the CPG by comparing performance rates for the 
various elements included in the CPG before and 
after its implementation. Adherence to the CPG was 
defined as a patient with perforated appendicitis 
who was managed without deviation from the 
protocol. After implementing the CPG, there was 
a significant reduction in patients receiving post-
operative laboratory tests (90% to 38%; P < 
.01), either ampicillin-sulbactam or piperacillin-
tazobactam during admission (92% to 18%; P < 
.01), and oral amoxicillin-clavulanate (68% to 6%; 
P < .01) at discharge. We did not see a significant 
decrease in overall or total antibiotic duration. There 
was a notable trend toward lower CT scan use at 
our institution. We observed a significant increase 
in practice patterns with total adherence to the CPG 
(4% to 64%; P < .01).
Post-operative complications examined are listed 
in Table 4. After CPG implementation, there was no 
significant change in the following post-operative 
parameters: placement of peripherally inserted 
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Post-operative labs, No. (%) 45 (90) 19 (38) <.01
Computed tomography rates
  Overall, No. (%) 25 (50) 20 (40) .31
  Outside hospital, No. (%)* 14 (50) 16 (43) .59
  Maine Medical Center, No. (%)† 11 (31) 4 (12) .06
Broad-spectrum antibiotics
  Intravenous, No. (%) 46 (92) 9 (18) <.01
  Oral, No. (%) 34 (68) 3 (6) <.01
  Total duration, mean (SD), d 11.02(3.3) 10.48 (3.5) .43
CPG adherence, No. (%) 2 (4) 32 (64) <.01
Abbreviations: CPG, clinical practice guideline. 
*See Table 2 for patient numbers. 
†Rate defined as percentage of patients without a prior CT scan who underwent CT scan at MMC 
emergency department. Includes patients who initially present to MMC and those transferred from 
referring facilities.
central catheters or central venous catheters, 
rates of interventional radiology intervention, need 
for reoperation, length of stay, percentage who 
completed prescribed antibiotic course, hospital 
admission/emergency department visit, resumption 
of antibiotics after completing a prescribed course, 
and mean follow-up duration.
DISCUSSION
By using the benchmarks outlined by the National 
Surgical Quality Improvement Program Pediatric 
and a current literature review, we successfully 
created a multidisciplinary CPG suited to our 
practice and population. Our new CPG resulted in 
significant changes in practice without increasing 
the rates of complications and while improving 
antibiotic stewardship and resource use. We will 
use these data to continue studying our patient 
population and further improve our clinical practice. 
We studied patients with perforated appendicitis 
because they encompass all phases of the CPG. 
This approach also allowed us to do a more complete 
assessment of adherence in the most clinically 






PICC/CVC, No. (%) 5 (10) 3 (6) .44
IR procedure/reoperation, No. (%) 3 (6) 4 (8) .70
Length of stay, mean (SD), d 4.98 (2.5) 4.46 (2.0) .25
Completed prescribed oral antibiotics, No. (%) 48 (96) 45 (90) .24
Readmit/ED visit, No. (%) 5 (10) 7 (14) .54
Antibiotics restarted, No. (%) 1 (2) 2 (4) .56
Follow-up, mean (SD), d 10.62 (7.5) 12.4 (8.0) .27
Abbreviations: CPG, clinical practice guideline; CVC, central venous catheters; ED, emergency department; 
IR, interventional radiology; PICC, peripherally inserted central catheter.
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severe patients. If patients with simple appendicitis 
were included, there would have been bias toward 
CPG adherence due to lack of post-operative 
antibiotic and laboratory use, as well as selection 
bias toward a healthy population and reduced 
complications. While our study design may bias 
against the CPG, we believe this approach is the 
most objective interval assessment of adherence.
We observed a significant increase in the age of 
patients presenting with a perforated appendix 
after CPG implementation. Reports correlated 
younger age at presentation with more advanced 
disease.15 However, the observed difference was 
not associated with differing clinical outcomes, 
suggesting that the age group difference was not 
clinically significant nor a confounding variable.
Protocol deviations in the study were reviewed 
to identify ways to improve adherence. For 
antimicrobial stewardship, the primary cause for 
non-adherence was the decision to continue the 
antibiotic regimen initiated at referring hospitals. 
Piperacillin-tazobactam monotherapy is easier 
to initiate and ensure adequate coverage than 
dual therapy in patients that may be transferring 
quickly to avoid antibiotic delay. We achieved 
statistical reduction in post-operative laboratory 
tests; however, this decrease was a significant 
contributor to all protocol deviations occurring within 
our institution. Before this CPG, our group obtained 
bloodwork before discharge, and this standard was 
difficult to alter. After the CPG was developed, we 
had multiple education sessions with residents who 
primarily wrote orders because as new learners, 
they joined the service after the initial educational 
roll-out. We will evaluate whether these additional 
educational sessions have reduced deviations.
The number of patients initially evaluated at a 
referring facility increased by 32% in the post-
CPG group. This evaluation likely affected the 
rates of overall CT scans, as there was a larger 
trend toward reduced CT scans at our institution 
(30% to 12%) than at referring facilities (50% to 
43%) during the same time; although, neither 
result is statistically significant. We believe that 
with further study and an increased sample size, 
we would see significantly reduced CT rates to 
diagnose perforated appendicitis at our institution. 
Additionally, all CT scans were reported toward our 
count, even if appendicitis was not the suspected 
initial diagnosis or indication for imaging. Because 
an unexpected diagnosis of appendicitis will 
continue to be made based on CT, we anticipate 
that CT rates can be decreased, but not eliminated, 
although elimination will remain our target.
As the tertiary care center for a rural state, there 
are times when application of the CPG may 
not be feasible or in the patient’s best interest. 
Transporting patients also carries potential adverse 
outcomes that were outside the scope of this study. 
Cost, burden on family, and traffic incidents weigh 
into the decision to transfer before or after CT scan, 
particularly on the outer perimeter of our referral 
base. We want to empower regional centers to 
make the best decisions for patients, and this effort 
is part of our outreach.
Implementation of the CPG most successfully 
reduced broad-spectrum antibiotic exposure 
and frequency of routine post-operative 
laboratory draws. There was concern with a 
high Pseudomonas frequency (20% of cultures) 
that choosing regimens without pseudomonal 
coverage in initial IV antibiotics would increase 
post-operative complications; however, we did not 
see this outcome. We hypothesize that adequate 
source control was enough to counteract the lack 
of pseudomonal coverage. The reduced post-
operative laboratory draws and reliance on clinical 
decision for when to discharge on oral antibiotics 
also did not adversely affect outcomes.
We reported that there was no significant difference 
in patients who completed the original course of 
prescribed antibiotics, but there may be some 
clinical difference between the groups. In the pre-
CPG cohort, 2 patients were reported as not taking 
the prescribed course of antibiotics because they 
were lost to follow-up and no documentation of 
completion was available. In the post-CPG cohort, 
3 of the 5 patients reported as not completing 
the course of antibiotics were lost to follow-up; 
however, 2 of the 5 had documented intolerance 
and reported gastrointestinal symptoms requiring 
a change in oral regimen with the successful 
completion of antibiotics. The post-CPG regimen 
was metronidazole-based, which has known 
gastrointestinal side effects and may be the 
contributing agent to these 2 cases.
There are some limitations to this study, most 
notably the rarity of adverse secondary outcomes. 
While we did not find a significant increase in the 
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measured complications, we are mindful that 
given the frequency of adverse events, our study 
might not have been large enough to detect them. 
Therefore, we are continuing to collect and monitor 
these important metrics. Additionally, we have a 
relatively short mean follow-up time, which may not 
account for complications that present to referral 
centers. As we are the primary children’s hospital 
for the state, most post-operative complications 
would be transferred and identified in our chart 
review; however, this belief is an assumption for 
which we have not done surveillance phone calls. 
Lastly, although we have documented a statistically 
significant change in practice associated 
with implementing the CPG, adherence after 
implementation was 64%. We defined successful 
implementation as adherence to the entire CPG, 
from presentation through discharge, knowing that 
this approach would provide more opportunities 
for non-adherence. This approach allowed us to 
better understand our own system and areas for 
further intervention. We are mindful that increasing 
adherence further may have a corresponding 
increase in adverse outcomes and will monitor 
this possibility as we continue to pursue complete 
adherence.
CONCLUSIONS
We successfully implemented an evidence-based, 
multidisciplinary CPG to decrease resource use, 
improve antimicrobial stewardship, and reduce 
radiation exposure for pediatric patients with 
suspected appendicitis. To further collaborate 
with referral centers, these data and CPG were 
presented at a statewide surgical chapter. We have 
also extended this CPG to referring emergency 
departments and have encouraged transfer 
initiation to lower barriers for interhospital discussion 
with centers without pediatric surgeons. We will 
continue to educate providers in multiple disciplines 
at our institution and conduct outreach to referring 
hospitals to further standardize management of 
pediatric appendicitis in our region.
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